» Articles » PMID: 29081082

Epoxyeicosatrienoic Acid Inhibits the Apoptosis of Cerebral Microvascular Smooth Muscle Cells by Oxygen Glucose Deprivation Via Targeting the JNK/c-Jun and MTOR Signaling Pathways

Overview
Journal Mol Cells
Publisher Elsevier
Date 2017 Oct 30
PMID 29081082
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

As a component of the neurovascular unit, cerebral smooth muscle cells (CSMCs) are an important mediator in the development of cerebral vascular diseases such as stroke. Epoxyeicosatrienoic acids (EETs) are the products of arachidonic acid catalyzed by cytochrome P450 epoxygenase. EETs are shown to exert neuroprotective effects. In this article, the role of EET in the growth and apoptosis of CSMCs and the underlying mechanisms under oxygen glucose deprivation (OGD) conditions were addressed. The viability of CMSCs was decreased significantly in the OGD group, while different subtypes of EETs, especially 14,15-EET, could increase the viability of CSMCs under OGD conditions. RAPA (serine/threonine kinase Mammalian Target of Rapamycin), a specific mTOR inhibitor, could elevate the level of oxygen free radicals in CSMCs as well as the anti-apoptotic effects of 14,15-EET under OGD conditions. However, SP600125, a specific JNK (c-Jun N-terminal protein kinase) pathway inhibitor, could attenuate oxygen free radicals levels in CSMCs as well as the anti-apoptotic effects of 14,15-EET under OGD conditions. These results strongly suggest that EETs exert protective functions during the growth and apoptosis of CSMCs, via the JNK/c-Jun and mTOR signaling pathways in vitro. We are the first to disclose the beneficial roles and underlying mechanism of 14,15-EET in CSMC under OGD conditions.

Citing Articles

Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF-1-Smad2/3 Signaling in a PPAR-Dependent Manner.

Tao J, Liu T, Zhang C, Zu C, Yang H, Liu Y Oxid Med Cell Longev. 2022; 2022:7265486.

PMID: 36275905 PMC: 9584742. DOI: 10.1155/2022/7265486.


14,15-Epoxyeicosatrienoic Acid Protect Against Glucose Deprivation and Reperfusion-Induced Cerebral Microvascular Endothelial Cells Injury by Modulating Mitochondrial Autophagy SIRT1/FOXO3a Signaling Pathway and TSPO Protein.

Qu Y, Cao J, Wang D, Wang S, Li Y, Zhu Y Front Cell Neurosci. 2022; 16:888836.

PMID: 35558879 PMC: 9086968. DOI: 10.3389/fncel.2022.888836.


Microglial Activation Is Associated With Vasoprotection in a Rat Model of Inflammatory Retinal Vasoregression.

Riemann S, Kolibabka M, Busch S, Lin J, Hoffmann S, Gretz N Front Physiol. 2021; 12:660164.

PMID: 33981252 PMC: 8107726. DOI: 10.3389/fphys.2021.660164.


Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration.

Sarparast M, Dattmore D, Alan J, Lee K Nutrients. 2020; 12(11).

PMID: 33207662 PMC: 7696575. DOI: 10.3390/nu12113523.


Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke.

Kloska A, Malinowska M, Gabig-Ciminska M, Jakobkiewicz-Banecka J Int J Mol Sci. 2020; 21(10).

PMID: 32443889 PMC: 7279232. DOI: 10.3390/ijms21103618.


References
1.
Sudhahar V, Shaw S, Imig J . Epoxyeicosatrienoic acid analogs and vascular function. Curr Med Chem. 2010; 17(12):1181-90. PMC: 2855336. DOI: 10.2174/092986710790827843. View

2.
Wang H, Lin L, Jiang J, Wang Y, Lu Z, Bradbury J . Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther. 2003; 307(2):753-64. DOI: 10.1124/jpet.103.052787. View

3.
Drobny M, Kurca E . Possible extrapyramidal system degradation in Parkinson's disease. Brain Res Bull. 2001; 53(4):425-30. DOI: 10.1016/s0361-9230(00)00367-1. View

4.
Iadecola C . Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004; 5(5):347-60. DOI: 10.1038/nrn1387. View

5.
von Leden R, Yauger Y, Khayrullina G, Byrnes K . Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: Oxidative Stress and Therapeutic Targets. J Neurotrauma. 2016; 34(4):755-764. PMC: 5335782. DOI: 10.1089/neu.2016.4486. View